Analyse
Analyses approfondies des marchés pharmaceutiques, des chaînes d'approvisionnement, de la technologie et de la réglementation
#CDMO ×
Analyse
30 août 2026•1 min de lecture
High Won Exchange Rate Affects Pharma & Bio Companies Differently
While a weak won usually boosts exporters, pharma and biotech firms see mixed effects as foreign revenue growth is offset by rising foreign‑currency costs for raw materials, debt and liabilities.
Analyse
26 août 2026•1 min de lecture
Kimball Electronics Pursues M&A to Expand Life‑Science CDMO Footprint in Europe and India
Kimball Electronics announced plans to grow its life‑science contract manufacturing capabilities through acquisitions in Europe and India.
1